Stock Research: Globus Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Globus Medical

NYSE:GMED US3795772082
90
  • Value
    98
  • Growth
    45
  • Safety
    Safety
    54
  • Combined
    86
  • Sentiment
    76
  • 360° View
    360° View
    90
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Globus Medical, Inc. develops and commercializes healthcare solutions for musculoskeletal disorders. It operates in the medical device industry, specializing in spinal, orthopedic, and neurosurgical procedures. In the last fiscal year, the company had a market cap of $7,564 million, profits of $1,699 million, and revenue of $2,519 million, with 5300 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 90 (better than 90% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Globus Medical are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Globus Medical. The consolidated Value Rank has an attractive rank of 54, which means that the share price of Globus Medical is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 54% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 98. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 76. But the consolidated Growth Rank has a low rank of 45, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 55 of its competitors have better growth. ...read more

more
Index
Robotics
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 31 69 47
Growth
45 95 71 63
Safety
Safety
98 19 95 95
Sentiment
76 78 26 40
360° View
360° View
90 37 57 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
40 45 19 28
Opinions Change
82 50 43 42
Pro Holdings
n/a 88 64 39
Market Pulse
67 63 23 93
Sentiment
76 78 26 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 31 69 47
Growth
45 95 71 63
Safety Safety
98 19 95 95
Combined
86 51 83 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
42 38 60 41
Price vs. Earnings (P/E)
45 33 56 45
Price vs. Book (P/B)
69 48 89 50
Dividend Yield
1 1 1 1
Value
54 31 69 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
45 42 100 37
Profit Growth
39 92 85 71
Capital Growth
53 96 37 45
Stock Returns
51 87 27 75
Growth
45 95 71 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
78 87 100 100
Refinancing
45 32 55 49
Liquidity
100 21 87 87
Safety Safety
98 19 95 95

Similar Stocks

Discover high‑ranked alternatives to Globus Medical and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.